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1. Introduction
  It is believed that approximately 80% of the third world 
population is almost entirely dependent on traditional 
medicine[1]. Application of phytotherapeutic medication 
especially in traditional medicine is a recognized profession 
and has played an important role as an alternative Medicare 
which involves direct use of plants for preventing and 
healing diseases and infections[2].
  Bridelia micrantha (B. micrantha) belongs to the Family 
Euphorbiaceae and is known as coast gold in English. The 
Igbo people of Southern Nigeria call it Ogaofia, Asha; the 
Yorubas call it Idaodan. Swahilis call it Mkarakaka. It is 
known as Musabayembe by the Bemba tribe in central 
Africa. Yoruba herbalists of western Nigeria use the 
bark for bringing full-term prolonged pregnancy[3]. In 
Ghana, a leaf decoction is given to expel guinea worm[4], 
and in Ivory Coast, it is a powerful purgative in cases of 
obstinate constipation and poisoning[5]. It is administered in 
various preparations in Senegal for stomach and intestinal 
complaints, sterility, oedema and in combination with other 
drug plant for shock. 
  Paracetamol is a mild analgesic and antipyretic agent 
which is safe and effective when taken in low doses 
Ingestion of high doses leads to acute liver failure 
accompanied by centri-lobular degeneration and necrosis 
in the liver of both man and experimental animals[6]. 
Toxicity of paracetamol is thought to be produced by 
N-acetyl-p-benzoquinine imine, a reactive electrophilic 
metabolite of a cytochrome P-450 mediated reaction.
  The present study is therefore designed to investigate the 
hepatoprotective and anti oxidant effects of the ethyl acetate 
leaf extract of B. micrantha.
2. Materials and methods
2.1. Preparation of plant material
  The fresh leaves of B. micrantha were obtained and 
identified by Mr. Ozioko, a taxonomist with Bioresources 
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Development and Conservation Programme (BDCP). They 
were dried at room temperature and pulverized into powder 
with a laboratory mill. The powder (1 000 g) was exhaustively 
extracted with ethyl acetate. The extraction was treated by 
cold maceration at 37 曟 with intermittent shaking for 48 h. 
The extract was concentrated by vacuum rotary evaporator 
and stored in a refrigerator at 4 曟.
2.2. Experimental animals                                                                                                           
  Wistar rats of both sex with weighing of 86-128 g were used 
as test animals. The animals were housed in cages at room 
temperature under light period of 16-18 h daily. All animals 
were fed ad libitum with Vital® pelleted feed and water.
2.3. Solutions, reagents, chemicals and equipment
  Freshly prepared solutions and analytical grade 
chemicals were used in all the experiments. Alloxan 
monohydrate (Sigma-Aldrich, Germany), 2, 2-diphenyl 
-1- picryl hydrazyl (Sigma-Aldrich, Germany), 2, 4, 6- tri 
(2-pyridyl)-s- triazine (Fluka), ascorbic acid ( Hopkins 
and Williams Ltd), Paracetamol (Emzor), Silymarin, (Roche, 
Germany), spectrophotometer (Spectrumlab, USA).
2.4. Acute toxicity study
  Six groups of albino rats of both sexes with each group 
containing five rats were used, bringing the total to 30 rats. 
Five of the groups were treated orally with varying doses 
of the B. micrantha extract at 500, 1 000, 1 500, 2 000 and 
3 000 mg/kg, respectively. The sixth group was given an 
equivalent volume of distilled water to serve as control. 
The animals were observed for toxic signs like excitability, 
dullness, diarrhea, inappetence and death over 72 hours.
2.5. Paracetamol-induced hepatotoxicity 
  Thirty six Wistar rats were used for the experiment. The 
animals were divided into six groups of six rats per group. 
Group one received distilled water for 14 days and served 
as normal control (no challenge with paracetamol). All other 
groups were challenged with a single dose of 2 000 mg/kg 
of paracetamol, per os prior to treatment which was done 
12 h after paracetamol administration. Group two received 
paracetamol only (negative control). Group three received 
silymarin (25 mg/kg) for 14 days. Groups four, five, and six 
received 75, 150 and 300 mg/kg of the ethyl acetate leaf 
extract of B. micrantha respectively for 14 days. After 12 h,
blood samples for biochemical studies were collected 
through the lacrimal vein of the rats into marked sample 
bottles. These were allowed to stand for 45 mins at room 
temperature. The serum was separated using a Pasteur 
pipette into sterile serum sample tubes from where they were 
drawn for biochemical assays. The method of Reithman and 
Frankel[7] was adopted for the alanine aminotransaminase 
(ALT) and aspartate aminotransferase (AST) assays. Alkaline 
phosphatase actvity (ALP) was estimated using the method 
of King EJ and King PR[8]. Bilirubin was determined using 
the method Tietz[9]. Total protein was estimated using the 
method of Johnson[10].  
2.6. Estimation of the antioxidant activity of B. micrantha 
using the 1, 1-Diphenynl-2-Picrylhydrazyl (DPPH) 
antioxidant assay method
  The method of Mensor[11] was adopted. 2 mL of test extract 
at concentrations of 10, 50, 100, 200 and 400 毺g/mL was 
each mixed with 1 mL of 0.5 mM DPPH (in methanol). 
Absorbance at 517 nm was taken after 30 minutes incubation 
in the dark at room temperature. The concentrations were 
prepared in triplicates. The percentage antioxidant activity 
was calculated as follows:  
% antioxidant activity[AA] = 100 -([absorbance of sample-
absorbance of blank] 伊 100)
       
Absorbance of control
  1 mL of methanol plus 2 mL of the extract was used as 
blank while 1 mL of 0.5 mM DPPH solution plus 2 mL of 
methanol was used as control. Ascorbic acid was used as 
reference standard.
2.7. Estimation of the antioxidant activity of B. micrantha 
using the Ferric Reducing Antioxidant Power FRAP assay 
method.
  The total antioxidant potential of sample was determined 
using a ferric reducing ability of plasma FRAP assay of 
Benzie and Strain as a measure of “antioxidant power”[12]. 
All determinations were performed in triplicates.
2.8. Data analysis
  Data are expressed as mean依SEM and were analyzed for 
significance by Dunnet’s test using the SPSS 16 software. In 
all cases, the criterion for statistical significance was P<0.05.
3. Results
  The ethyl acetate leaf extract of B. micrantha was brownish 
green in colour. The total solid recovered from the extraction 
was 115.28 g. No death was recorded in the rats treated orally 
with varying doses (500 - 3 000 mg/kg) of the extract within 
72 h. However, rats treated with 3 000 mg/kg of the extract 
showed transient dullness, which disappeared 1 h after the 
administration of the extract. Results of the hepatoprotective 
study (Table 1) showed that B. micrantha had a positive 
dose dependent influence on the level of AST in rats, with 
the dose of 300 mg/kg being better than the results with 
Silymarin. It caused a decrease in the level of AST in the 
rats given PCM from (129.47依0.92) IU/L to (57.78依1.71) IU/L
(P<0.05). This was lower than the value for Silymarin which 
was (59.92依1.41) IU/L. ALT concentration was reduced from 
(150.18依2.23) IU/L to (79.10依2.01) IU/L (P<0.05).  ALP was 
reduced from (49.86依0.85) IU/L to (29.64依1.53) IU/L (P<0.05).     
   Total bilirubin was reduced from (2.14依0.10) mg/dL to 
(0.18依0.07) mg/dL (P<0.05). Total protein was increased 
from (4.26依0.30) mg/dL to (6.20依0.19) mg/dL (P<0.05). The 
extract of B. micrantha had an increasing percentage 
antioxidant activity with increasing concentrations after 30 
min incubation in the dark. This was compared with DPPH 
assay of L-ascorbic acid (Figure 1). At the concentration of 
400 毺g/mL, B. micrantha had a 97.7% antioxidant activity 
while ascorbic acid had 79.98%. The FRAP values were 
0.016, 0.390, 0.455, 0.601 and 1.382 毺M at 10, 50, 100, 200 
and 400 毺g/mL respectively. The extract of B. micrantha 
showed increased ferric reducing antioxidant power which 
was dependent on the concentration of the extract showing 
the highest FRAP value at 400 毺g/mL (Figure 2).      
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Figure 1. DPPH  antioxidant activity of B. micrantha.
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Figure 2. FRAP assay of B. micrantha.
Table 1
The effect of the ethyl acetate leaf extract of B. micrantha on biochemical parameters.
Group AST (IU/L) ALT (IU/L) ALP (IU/L) Total bilirubin (mg/dL) Total protein (mg/dL)
Normal control   55.15依3.31a   78.13依3.10a 28.38依2.73a 0.17依0.01a 6.53依0.18 a
PCM only 129.47依0.92 150.18依2.23 49.86依0.85 2.14依0.10 4.26依0.30 
Silymarin+PCM   59.92依1.41a   82.54依1.52a 31.03依1.50a 0.18依0.03 a 6.19依0.16 a
Extract (75 mg/kg) +PCM 124.83依1.20 133.35依1.65a 37.81依1.11a 2.00依0.30 5.21依0.25 a
Extract(150 mg/kg) + PCM   82.72依1.99a 119.68依1.10a 30.09依1.60a 0.20依0.19 a 5.61依0.20 
Extract (300 mg/kg)+ PCM   57.78依1.71a   79.10依2.01a 29.64依1.53a 0.18依0.07 a 6.20依0.19 a
  a means significantly different from group treated with only PCM P<0.05.
4. Discussion
  The absence of signs of toxicity and death in rats treated 
with the extract showed that it is relatively safe and 
explains why this plant has a wide acceptance in traditional 
medicine practice. Ethyl acetate extract of B. micrantha 
had hepatoprotective effects on the Wistar rats especially at 
300 mg/kg, which were better than that of the known 
Silymarin. Thus, this plant has the ability to help in the 
regeneration of damaged hepatic cells and will be very 
useful in the treatment of hepatic diseases, being safe, 
cheap and readily available[7]. The results of the antioxidant 
assays (DPPH and FRAP) showed that the methanol leaf 
extract of B. micrantha has antioxidant properties. It was 
able to scavenge the free radicals produced by DPPH, and 
also reduce ferric oxide appreciably. FRAP assay measures 
the change in absorbance at 593 nm owing to the formation 
of a blue colored Fe11-tripyridyltriazine compound from 
colorless oxidized Fe111 form by the action of electron 
donating antioxidants. 
  It can be concluded from the results that the oral 
administration of the ethyl acetate leaf extract of B. 
micrantha is beneficial in improving the antioxidant status 
of the body since its DPPH antioxidant assays showed better 
free radical scavenging activity than L-ascorbic acid[9]. 
The experiment also revealed that ethyl acetate extracts 
of B. micrantha has a better hepatoprotective capacity 
than Silymarin. Further pharmacological and biochemical 
investigations are going on to find out the mechanism of action 
and also identify the active compounds responsible for the 
hepatoprotective and antioxidant activities respectively.
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